期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

药物洗脱支架治疗冠心病合并糖尿病患者的预后分析 被引量：2

原文传递
导出
摘要 糖尿病（DM）是发生冠状动脉疾病的一个危险因素，约20％．30％的糖尿病患者可能发生急性冠脉综合征（ACS）。而且糖尿病患者经冠状血管介入（PCI）术后发生心血管意外和心肌梗死（MI）的概率较高，
作者 宋毓青 吴其明
机构地区 首都医科大学附属北京地坛医院心内科
出处 《中国基层医药》 CAS 2011年第24期3379-3381,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 冠心病合并糖尿病 预后分析 患者 支架治疗 药物洗脱 冠状动脉疾病 急性冠脉综合征 心血管意外
分类号 R587 [医药卫生—内分泌] R541 [医药卫生—心血管疾病]
  • 相关文献

参考文献20

  • 1Capodanno D,Angiolillo DJ.Diabetus mellitus:the scary killer haunting silently.Euro Intervention,2010,5 (8):891-897.
  • 2Garg P,Cohen DJ,Gaziano T,et al.Balancing the risks of restenosis and stent thrombosis in brae-metal versus drug-eluting stents:results of a decision analytic model.J Am Coll Cardiol,2008,51:1844-1853.
  • 3Scheen AJ,Warzee F,Legrand VM.Drug-eluting stents:meta-analysis in diabetic patients.Eur Heart J,2004,25 (23):2167-2168.
  • 4李淑娟.Endeavor^(TM)支架显示一致的临床结果和卓越的安全性[J].中国介入心脏病学杂志,2006,14(2):96-96. 被引量：2
  • 5Lee MS,Jurewitz D,Zimmer R,et al.Impact of diabetes and acute coronary syndrome on survival in patients treated with drug-eluting stents.Catheter Cardiovasc Interv,2008,72(7):909-914.
  • 6孙华保,陈杰,李泽林,刘年安,李庆军,梁国钦,王广兴.紫杉醇药物洗脱支架应用的临床观察[J].中国医师杂志,2006,8(6):849-850. 被引量：3
  • 7Hasin T,Hochadel M,Gitt AK,et al.Comparison of treatment and outcome of acute coronary syndrome in patients with versus patients without diabetes mellitus.Am J Cardiol,2009,103 (6):772-778.
  • 8Farkouh ME,Aneja A,Reeder GS,et al.Usefulness of diabetes mellitus to predict long-term outcomes in patients with unstable angina pectoris.Am J Cardiol,2009,104(4):492-497.
  • 9Thygesen K,Alpert JS,White HD.Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction.Universal definition of myocardial infarction.Eur Heart J,2007,28(20):2525-2538.
  • 10陈纪林,高润霖,杨跃进,乔树宾,秦学文,姚民,刘海波,吴永健,袁晋青,陈珏,徐波.雷帕霉素药物洗脱支架在冠心病复杂病变中应用的近远期疗效[J].中华心血管病杂志,2004,32(10):867-869. 被引量：28

二级参考文献10

  • 1Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med,2002, 346:1773-1780.
  • 2Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med, 2003, 349:1315-1323.
  • 3Schofer J, Schluter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet, 2003, 362:1093-1099.
  • 4Sousa JE, Costa MA, Sousa AG, et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation, 2003, 107:381-383.
  • 5Mercado N,Boersma E,Wijns W,et al.Clinical and quantitative coronary angiographic predictiors of coronary restenosis:a comparative analysis from the balloon-to-stent era.J Am Coll Cardiol,2001,38(3):645-652.
  • 6Babapulle MN,Joseph L,Belisle P,et al.A hierarchical bayesian meta-analysis of randomised clinical trials of drug-eluting stents.Lancet,2004,364(9434):583-591.
  • 7Nobuyoshi M,Kimura T,Nosaka H,et al.Restenosis after successful percutaneous transhuminal coronary angioplasty:serial angiographic follow-up of 229 patients.J Am Coll Cardiol,1988,12(3):616-623.
  • 8Grube E,Silber S,Hauptmann KE,et al.TAXUS I:six-and twelve-month results from a randomized,double-blind trial on a slow-release paclitaxel-eluting stent fro de novo coronary lesions.Circulation,2003,107(1):38-42.
  • 9Colombo A,Drzewiecki J,Banning A,et al.Randomized study to assess the effectiveness of slow-and moderate-release polymer-based paclitaxel-eluting stent for coronary artery lesions.Circulation,2003,108(7):788-794.
  • 10Stone GW,Ellis SG,Cox DA,et al.One-year clinical results with the slow-release,polymer-based,paclitaxel-eluting TAXUS stent:the TAXUS-IV trial.Circulation,2004,109(16):1942-1947.

共引文献59

同被引文献10

二级引证文献8

中国基层医药
2011年 第24期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部